arrow_back Civic Audit
Share share

Additional Funding for COVID-19 and Future Pandemic Preparedness

This act allocates $10 billion for the production and distribution of medical supplies, tests, and vaccines related to COVID-19. These funds aim to ensure the availability of essential medical materials for citizens and prepare the country for future health threats. After 2022, the funds can be used to respond to other serious public health emergencies.
Key points
Allocates $10 billion for purchasing and producing masks, tests, vaccines, and other medical equipment to combat COVID-19.
Funds can be used for building or upgrading factories that produce medical supplies.
After 2022, unused funds can be directed towards responding to other significant public health emergencies.
The President can delegate authority to manage these funds to the Secretary of Health and Human Services or other agencies.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
Print number: 117_HR_1720
Sponsor: Rep. Vargas, Juan [D-CA-51]
Process start date: 2021-03-09
System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

COVID–19 Medical Production Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_HR_1720.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2021-03-09.

What are the main provisions?

Key points include:

  • Allocates $10 billion for purchasing and producing masks, tests, vaccines, and other medical equipment to combat COVID-19.
  • Funds can be used for building or upgrading factories that produce medical supplies.
  • After 2022, unused funds can be directed towards responding to other significant public health emergencies.
  • The President can delegate authority to manage these funds to the Secretary of Health and Human Services or other agencies.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Vargas, Juan [D-CA-51].

What is the latest detailed status?

The latest detailed status is: Referred to the House Committee on Financial Services.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-27.

What is the impact of this bill?

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge.

CATEGORIES

Health Public Investments